{
  "name": "Polaryx Therapeutics, Inc.",
  "legal_name": "Polaryx Therapeutics, Inc.",
  "ticker": "PLYX",
  "tickers": [
    "PLYX"
  ],
  "cik": "0002075320",
  "page_url": "https://steadybase.io/company/polaryx-therapeutics-inc/",
  "markdown_url": "https://steadybase.io/company/polaryx-therapeutics-inc.md",
  "json_url": "https://steadybase.io/company/polaryx-therapeutics-inc.json",
  "as_of": "2026-11-21",
  "last_filed": "2026-11-12",
  "industry": {
    "sic": "2834",
    "description": "Pharmaceutical Preparations"
  },
  "headquarters": {
    "city": "Paramus",
    "state": "NJ",
    "country": "US"
  },
  "exchanges": [
    "Nasdaq"
  ],
  "fiscal_year_end": "December 31",
  "filer_category": "<br>Emerging growth company",
  "state_of_incorporation": "WY",
  "website": "polaryx.com",
  "investor_relations_url": "https://investors.polaryx.com",
  "linkedin_company_url": "https://www.linkedin.com/company/polaryxtherapeutics",
  "summary": {
    "text": "PLX-200 (gemfibrozil), our most advanced drug candidate, is an oral small molecule for the treatment of LSDs. PLX-200 is a repurposed, reformulated drug that we are pursuing through a 505(b)(2) regulatory pathway and is designed to be administered through a novel and proprietary oral solution. We are advancing PLX-200 through a Phase 2 proof-of-concept basket trial, which we refer to as SOTERIA (PLX-200-600), and expect to initiate this trial in the second half of 2026.",
    "section": "Item 1. Business",
    "period_end": "2025-12-31",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/ea0281719-10k_polaryx.htm"
  },
  "key_facts": [
    {
      "key": "operating_income",
      "label": "Operating income",
      "value": -7821000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-03-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html",
      "text": "Operating income: -$7.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 24, 2026)."
    },
    {
      "key": "net_income",
      "label": "Net income",
      "value": -8985000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "filing_fact",
      "form": "10-K",
      "filed": "2026-03-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html",
      "text": "Net income: -$9.0M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 24, 2026)."
    },
    {
      "key": "sga",
      "label": "SG&A",
      "value": 1555000,
      "unit": "USD",
      "period_start": "2025-01-01",
      "period_end": "2025-12-31",
      "basis": "derived",
      "form": "10-K",
      "filed": "2026-03-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html",
      "text": "SG&A: $1.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 24, 2026)."
    },
    {
      "key": "employees",
      "label": "Employees",
      "value": 11,
      "unit": "people",
      "period_end": "2025-12-31",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/ea0281719-10k_polaryx.htm",
      "text": "Employees: 11 as of Dec 31, 2025, as reported in an SEC filing."
    },
    {
      "key": "shares_outstanding",
      "label": "Shares outstanding",
      "value": 49845993,
      "unit": "shares",
      "period_end": "2026-10-31",
      "form": "10-Q",
      "filed": "2026-11-12",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026118950/0001213900-26-118950-index.html",
      "text": "Shares outstanding: 49,845,993 as of Oct 31, 2026 (10-Q filed Nov 12, 2026)."
    },
    {
      "key": "auditor",
      "label": "Auditor",
      "value": "Grant Thornton LLP",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/ea0281719-10k_polaryx.htm",
      "text": "Auditor: Grant Thornton LLP, Edison, New Jersey, named in the latest 10-K."
    }
  ],
  "metrics": {
    "operating_income": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": -7821000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": -4352000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html"
      }
    ],
    "net_income": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": -8985000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": -30356000,
        "unit": "USD",
        "basis": "filing_fact",
        "form": "10-K",
        "filed": "2026-03-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html"
      }
    ],
    "sga": [
      {
        "period_start": "2025-01-01",
        "period_end": "2025-12-31",
        "value": 1555000,
        "unit": "USD",
        "basis": "derived",
        "form": "10-K",
        "filed": "2026-03-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html"
      },
      {
        "period_start": "2024-01-01",
        "period_end": "2024-12-31",
        "value": 1541000,
        "unit": "USD",
        "basis": "derived",
        "form": "10-K",
        "filed": "2026-03-24",
        "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/0001213900-26-033064-index.html"
      }
    ]
  },
  "next_earnings": {
    "date": "2027-02-11",
    "confidence": "low",
    "webcast_url": null
  },
  "people": [
    {
      "name": "Alex Keun Mo Yang",
      "title": "Chief Executive Officer",
      "role": "both",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-05-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026062322/0001213900-26-062322-index.htm"
    },
    {
      "name": "G. Michael Landis",
      "title": "Chief Financial Officer",
      "role": "both",
      "linkedin_url": null,
      "form": "4",
      "filed": "2026-02-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026018845/0001213900-26-018845-index.htm"
    },
    {
      "name": "Lisa L. Bollinger, M.D.",
      "title": "Chief Medical Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/ea0281719-10k_polaryx.htm"
    },
    {
      "name": "Andrew John O.",
      "title": "Chief Investment Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "3",
      "filed": "2026-01-29",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026009564/0001213900-26-009564-index.htm"
    },
    {
      "name": "Lisa Bollinger",
      "title": "Chief Medical Officer",
      "role": "officer",
      "linkedin_url": null,
      "form": "3",
      "filed": "2026-01-29",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026009567/0001213900-26-009567-index.htm"
    },
    {
      "name": "Francis A. Braun III",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/ea0281719-10k_polaryx.htm"
    },
    {
      "name": "Mitchel Berger, M.D.",
      "title": "Director",
      "role": "director",
      "linkedin_url": null,
      "form": "10-K",
      "filed": "2026-03-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/ea0281719-10k_polaryx.htm"
    }
  ],
  "events_8k": [
    {
      "filed": "2026-09-14",
      "items": [
        {
          "item": "5.07",
          "label": "Submission of matters to a vote of security holders",
          "signal": "governance"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/ea0305352-8k_polaryx.htm"
    },
    {
      "filed": "2026-09-01",
      "items": [
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026096235/ea0303928-8k_polaryx.htm"
    },
    {
      "filed": "2026-07-21",
      "items": [
        {
          "item": "5.02",
          "label": "Departure or appointment of directors or officers; compensation",
          "signal": "leadership_change"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026080041/ea0298434-8k_polaryx.htm"
    },
    {
      "filed": "2026-07-17",
      "items": [
        {
          "item": "5.08",
          "label": "Item 5.08",
          "signal": null
        },
        {
          "item": "8.01",
          "label": "Other events",
          "signal": "other"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026078912/ea0298274-8k_polaryx.htm"
    },
    {
      "filed": "2026-05-28",
      "items": [
        {
          "item": "1.01",
          "label": "Entry into a material definitive agreement",
          "signal": "deal"
        },
        {
          "item": "3.02",
          "label": "Unregistered sales of equity securities",
          "signal": "financing"
        },
        {
          "item": "7.01",
          "label": "Regulation FD disclosure",
          "signal": "disclosure"
        },
        {
          "item": "9.01",
          "label": "Financial statements and exhibits",
          "signal": "exhibits"
        }
      ],
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026062155/ea0291692-8k_polaryx.htm"
    }
  ],
  "insider_trades": [
    {
      "owner": "Alex Keun Mo Yang",
      "role": "Chief Executive Officer",
      "action": "bought",
      "code": "P",
      "shares": 88453,
      "value_usd": 360004,
      "date": "2026-05-27",
      "filed": "2026-05-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026062322/0001213900-26-062322-index.htm"
    },
    {
      "owner": "Partners Healthcare Ltd Mstone",
      "role": "Director",
      "action": "bought",
      "code": "P",
      "shares": 88453,
      "value_usd": 360004,
      "date": "2026-05-27",
      "filed": "2026-05-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026062322/0001213900-26-062322-index.htm"
    },
    {
      "owner": "G. Michael Landis",
      "role": "Chief Financial Officer",
      "action": "bought",
      "code": "P",
      "shares": 2867,
      "value_usd": 7999,
      "date": "2026-02-18",
      "filed": "2026-02-20",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026018845/0001213900-26-018845-index.htm"
    }
  ],
  "quotes": [],
  "latest_filings": [
    {
      "form": "8-K",
      "filed": "2026-09-14",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026099416/ea0305352-8k_polaryx.htm"
    },
    {
      "form": "10-K",
      "filed": "2026-03-24",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026033064/ea0281719-10k_polaryx.htm"
    },
    {
      "form": "10-Q",
      "filed": "2026-08-13",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026089118/ea0301429-10q_polaryx.htm"
    },
    {
      "form": "DEF 14A",
      "filed": "2026-07-28",
      "source_url": "https://www.sec.gov/Archives/edgar/data/2075320/000121390026082339/ea0298291-01.htm"
    }
  ],
  "source": "SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from."
}